|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: DLD |
Gene summary for DLD |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | DLD | Gene ID | 1738 |
| Gene name | dihydrolipoamide dehydrogenase | |
| Gene Alias | DLDD | |
| Cytomap | 7q31.1 | |
| Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | A0A024R713 |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 1738 | DLD | HTA11_347_2000001011 | Human | Colorectum | AD | 1.03e-02 | 3.25e-01 | -0.1954 |
| 1738 | DLD | A015-C-203 | Human | Colorectum | FAP | 2.35e-09 | -2.03e-01 | -0.1294 |
| 1738 | DLD | A002-C-201 | Human | Colorectum | FAP | 3.38e-02 | -1.69e-01 | 0.0324 |
| 1738 | DLD | A001-C-108 | Human | Colorectum | FAP | 3.01e-06 | -2.07e-01 | -0.0272 |
| 1738 | DLD | A002-C-205 | Human | Colorectum | FAP | 1.38e-05 | -2.20e-01 | -0.1236 |
| 1738 | DLD | A001-C-104 | Human | Colorectum | FAP | 1.16e-03 | -1.55e-01 | 0.0184 |
| 1738 | DLD | A015-C-006 | Human | Colorectum | FAP | 8.38e-04 | -2.44e-01 | -0.0994 |
| 1738 | DLD | A015-C-106 | Human | Colorectum | FAP | 1.54e-05 | -1.69e-01 | -0.0511 |
| 1738 | DLD | A002-C-114 | Human | Colorectum | FAP | 1.78e-05 | -2.53e-01 | -0.1561 |
| 1738 | DLD | A015-C-104 | Human | Colorectum | FAP | 5.69e-09 | -2.02e-01 | -0.1899 |
| 1738 | DLD | A001-C-014 | Human | Colorectum | FAP | 3.64e-05 | -1.81e-01 | 0.0135 |
| 1738 | DLD | A002-C-016 | Human | Colorectum | FAP | 8.52e-10 | -1.99e-01 | 0.0521 |
| 1738 | DLD | A001-C-203 | Human | Colorectum | FAP | 3.93e-06 | -1.69e-01 | -0.0481 |
| 1738 | DLD | A002-C-116 | Human | Colorectum | FAP | 1.25e-08 | -1.62e-01 | -0.0452 |
| 1738 | DLD | A014-C-008 | Human | Colorectum | FAP | 3.16e-02 | -1.97e-01 | -0.191 |
| 1738 | DLD | A018-E-020 | Human | Colorectum | FAP | 7.38e-04 | -1.99e-01 | -0.2034 |
| 1738 | DLD | F034 | Human | Colorectum | FAP | 2.65e-06 | -2.06e-01 | -0.0665 |
| 1738 | DLD | CRC-3-11773 | Human | Colorectum | CRC | 2.90e-04 | -1.81e-01 | 0.2564 |
| 1738 | DLD | LZE2T | Human | Esophagus | ESCC | 4.29e-02 | 6.61e-01 | 0.082 |
| 1738 | DLD | LZE4T | Human | Esophagus | ESCC | 7.09e-14 | 4.13e-01 | 0.0811 |
| Page: 1 2 3 4 5 6 7 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Colorectum (GSE201348) |  | FAP: Familial adenomatous polyposis |
| CRC: Colorectal cancer | ||
| Colorectum (HTA11) |  | AD: Adenomas |
| SER: Sessile serrated lesions | ||
| MSI-H: Microsatellite-high colorectal cancer | ||
| MSS: Microsatellite stable colorectal cancer | ||
| Esophagus |  | ESCC: Esophageal squamous cell carcinoma |
| HGIN: High-grade intraepithelial neoplasias | ||
| LGIN: Low-grade intraepithelial neoplasias | ||
| Liver |  | HCC: Hepatocellular carcinoma |
| NAFLD: Non-alcoholic fatty liver disease | ||
| Oral Cavity |  | EOLP: Erosive Oral lichen planus |
| LP: leukoplakia | ||
| NEOLP: Non-erosive oral lichen planus | ||
| OSCC: Oral squamous cell carcinoma | ||
| Skin |  | AK: Actinic keratosis |
| cSCC: Cutaneous squamous cell carcinoma | ||
| SCCIS:squamous cell carcinoma in situ | ||
| Thyroid |  | ATC: Anaplastic thyroid cancer |
| HT: Hashimoto's thyroiditis | ||
| PTC: Papillary thyroid cancer |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| GO:00060851 | Liver | HCC | acetyl-CoA biosynthetic process | 14/7958 | 18/18723 | 2.57e-03 | 1.23e-02 | 14 |
| GO:00061031 | Liver | HCC | 2-oxoglutarate metabolic process | 14/7958 | 18/18723 | 2.57e-03 | 1.23e-02 | 14 |
| GO:0006086 | Liver | HCC | acetyl-CoA biosynthetic process from pyruvate | 9/7958 | 11/18723 | 9.51e-03 | 3.60e-02 | 9 |
| GO:002290018 | Oral cavity | OSCC | electron transport chain | 126/7305 | 175/18723 | 6.65e-19 | 8.42e-17 | 126 |
| GO:000609118 | Oral cavity | OSCC | generation of precursor metabolites and energy | 286/7305 | 490/18723 | 1.45e-18 | 1.71e-16 | 286 |
| GO:000906018 | Oral cavity | OSCC | aerobic respiration | 133/7305 | 189/18723 | 1.79e-18 | 2.02e-16 | 133 |
| GO:004533318 | Oral cavity | OSCC | cellular respiration | 153/7305 | 230/18723 | 2.07e-17 | 1.87e-15 | 153 |
| GO:004277318 | Oral cavity | OSCC | ATP synthesis coupled electron transport | 75/7305 | 95/18723 | 1.95e-15 | 1.33e-13 | 75 |
| GO:004277518 | Oral cavity | OSCC | mitochondrial ATP synthesis coupled electron transport | 75/7305 | 95/18723 | 1.95e-15 | 1.33e-13 | 75 |
| GO:002290418 | Oral cavity | OSCC | respiratory electron transport chain | 86/7305 | 114/18723 | 2.43e-15 | 1.63e-13 | 86 |
| GO:001598018 | Oral cavity | OSCC | energy derivation by oxidation of organic compounds | 190/7305 | 318/18723 | 4.10e-14 | 2.26e-12 | 190 |
| GO:001964618 | Oral cavity | OSCC | aerobic electron transport chain | 68/7305 | 87/18723 | 9.88e-14 | 5.17e-12 | 68 |
| GO:004603420 | Oral cavity | OSCC | ATP metabolic process | 166/7305 | 277/18723 | 1.16e-12 | 5.12e-11 | 166 |
| GO:00435434 | Oral cavity | OSCC | protein acylation | 149/7305 | 243/18723 | 1.33e-12 | 5.80e-11 | 149 |
| GO:000611919 | Oral cavity | OSCC | oxidative phosphorylation | 96/7305 | 141/18723 | 2.33e-12 | 9.75e-11 | 96 |
| GO:000756818 | Oral cavity | OSCC | aging | 194/7305 | 339/18723 | 6.18e-12 | 2.33e-10 | 194 |
| GO:000612018 | Oral cavity | OSCC | mitochondrial electron transport, NADH to ubiquinone | 42/7305 | 51/18723 | 2.63e-10 | 7.31e-09 | 42 |
| GO:000675318 | Oral cavity | OSCC | nucleoside phosphate metabolic process | 247/7305 | 497/18723 | 6.28e-07 | 8.96e-06 | 247 |
| GO:000911719 | Oral cavity | OSCC | nucleotide metabolic process | 243/7305 | 489/18723 | 7.80e-07 | 1.09e-05 | 243 |
| GO:001969319 | Oral cavity | OSCC | ribose phosphate metabolic process | 199/7305 | 396/18723 | 2.97e-06 | 3.64e-05 | 199 |
| Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| hsa01200 | Colorectum | AD | Carbon metabolism | 55/2092 | 115/8465 | 5.53e-08 | 8.42e-07 | 5.37e-07 | 55 |
| hsa00620 | Colorectum | AD | Pyruvate metabolism | 28/2092 | 47/8465 | 3.71e-07 | 5.41e-06 | 3.45e-06 | 28 |
| hsa00020 | Colorectum | AD | Citrate cycle (TCA cycle) | 20/2092 | 30/8465 | 1.43e-06 | 1.77e-05 | 1.13e-05 | 20 |
| hsa00010 | Colorectum | AD | Glycolysis / Gluconeogenesis | 34/2092 | 67/8465 | 3.63e-06 | 4.34e-05 | 2.77e-05 | 34 |
| hsa00280 | Colorectum | AD | Valine, leucine and isoleucine degradation | 25/2092 | 48/8465 | 3.97e-05 | 3.41e-04 | 2.18e-04 | 25 |
| hsa00640 | Colorectum | AD | Propanoate metabolism | 18/2092 | 32/8465 | 1.33e-04 | 1.11e-03 | 7.08e-04 | 18 |
| hsa00310 | Colorectum | AD | Lysine degradation | 27/2092 | 63/8465 | 1.17e-03 | 7.75e-03 | 4.94e-03 | 27 |
| hsa00630 | Colorectum | AD | Glyoxylate and dicarboxylate metabolism | 14/2092 | 30/8465 | 7.25e-03 | 2.97e-02 | 1.89e-02 | 14 |
| hsa012001 | Colorectum | AD | Carbon metabolism | 55/2092 | 115/8465 | 5.53e-08 | 8.42e-07 | 5.37e-07 | 55 |
| hsa006201 | Colorectum | AD | Pyruvate metabolism | 28/2092 | 47/8465 | 3.71e-07 | 5.41e-06 | 3.45e-06 | 28 |
| hsa000201 | Colorectum | AD | Citrate cycle (TCA cycle) | 20/2092 | 30/8465 | 1.43e-06 | 1.77e-05 | 1.13e-05 | 20 |
| hsa000101 | Colorectum | AD | Glycolysis / Gluconeogenesis | 34/2092 | 67/8465 | 3.63e-06 | 4.34e-05 | 2.77e-05 | 34 |
| hsa002801 | Colorectum | AD | Valine, leucine and isoleucine degradation | 25/2092 | 48/8465 | 3.97e-05 | 3.41e-04 | 2.18e-04 | 25 |
| hsa006401 | Colorectum | AD | Propanoate metabolism | 18/2092 | 32/8465 | 1.33e-04 | 1.11e-03 | 7.08e-04 | 18 |
| hsa003101 | Colorectum | AD | Lysine degradation | 27/2092 | 63/8465 | 1.17e-03 | 7.75e-03 | 4.94e-03 | 27 |
| hsa006301 | Colorectum | AD | Glyoxylate and dicarboxylate metabolism | 14/2092 | 30/8465 | 7.25e-03 | 2.97e-02 | 1.89e-02 | 14 |
| hsa012006 | Colorectum | FAP | Carbon metabolism | 38/1404 | 115/8465 | 1.04e-05 | 1.44e-04 | 8.76e-05 | 38 |
| hsa006406 | Colorectum | FAP | Propanoate metabolism | 15/1404 | 32/8465 | 6.21e-05 | 6.10e-04 | 3.71e-04 | 15 |
| hsa003104 | Colorectum | FAP | Lysine degradation | 23/1404 | 63/8465 | 1.04e-04 | 9.46e-04 | 5.76e-04 | 23 |
| hsa000106 | Colorectum | FAP | Glycolysis / Gluconeogenesis | 24/1404 | 67/8465 | 1.05e-04 | 9.46e-04 | 5.76e-04 | 24 |
| Page: 1 2 3 4 5 6 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| DLD | SNV | Missense_Mutation | c.797N>C | p.Gln266Pro | p.Q266P | P09622 | protein_coding | tolerated(0.09) | possibly_damaging(0.503) | TCGA-A8-A08J-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | PD | |
| DLD | SNV | Missense_Mutation | c.83N>T | p.Ser28Phe | p.S28F | P09622 | protein_coding | tolerated(0.66) | benign(0) | TCGA-AO-A03T-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cyclophosphamide | SD | |
| DLD | SNV | Missense_Mutation | novel | c.729A>C | p.Glu243Asp | p.E243D | P09622 | protein_coding | deleterious(0.02) | probably_damaging(0.998) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
| DLD | SNV | Missense_Mutation | c.219N>G | p.Asn73Lys | p.N73K | P09622 | protein_coding | deleterious(0) | possibly_damaging(0.511) | TCGA-CA-6719-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
| DLD | SNV | Missense_Mutation | c.339N>A | p.Met113Ile | p.M113I | P09622 | protein_coding | tolerated(0.31) | benign(0) | TCGA-CK-4951-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
| DLD | SNV | Missense_Mutation | c.1168C>T | p.Pro390Ser | p.P390S | P09622 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-G4-6302-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
| DLD | SNV | Missense_Mutation | rs371807385 | c.944G>A | p.Arg315Gln | p.R315Q | P09622 | protein_coding | deleterious(0.01) | probably_damaging(1) | TCGA-WS-AB45-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
| DLD | SNV | Missense_Mutation | rs201652869 | c.875C>T | p.Ser292Phe | p.S292F | P09622 | protein_coding | deleterious(0.02) | possibly_damaging(0.727) | TCGA-AG-A02N-01 | Colorectum | rectum adenocarcinoma | Male | >=65 | I/II | Chemotherapy | folinic | CR |
| DLD | insertion | Frame_Shift_Ins | novel | c.626_627insA | p.Val212SerfsTer32 | p.V212Sfs*32 | P09622 | protein_coding | TCGA-AA-3966-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
| DLD | deletion | Frame_Shift_Del | c.627delN | p.Val212PhefsTer12 | p.V212Ffs*12 | P09622 | protein_coding | TCGA-AZ-6598-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
| Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |